NewAmsterdam Pharma Co N.V. (NAMS): SCHEDULE 13D/A filed Sep 30, 2025

Form type

SCHEDULE 13D/A

Filing date

Sep 30, 2025

Accession number

0001193125-25-225170

Filer

NewAmsterdam Pharma Co N.V. (CIK 1936258)